A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates.

Source:http://linkedlifedata.com/resource/pubmed/id/7715908

Download in:

View as

General Info

PMID
7715908